Sergio Traversa, Chief Executive Officer at RELMADA THERAPEUTICS, INC. (RLMD), bought 280,000 shares at $2.99 ($790K) on 2024-09-11, disclosed to the SEC on 2024-09-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.71 | 55,579 | $151K | 19.1% |
| 2 | $2.71 | 55,579 | $151K | 19.1% |
| 3 | $2.75 | 33,014 | $91K | 11.5% |
| 4 | $2.75 | 33,014 | $91K | 11.5% |
| 5 | $2.99 | 51,407 | $154K | 19.5% |
| 6 | $2.99 | 51,407 |
| $154K |
| 19.5% |
| Total | $2.82 avg | 280,000 | $790K | 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $600K | — | Filing → |
| RLMD | BUY | 2025-08-28 | $265K | — | Filing → |
| RLMD | BUY | 2025-05-20 | $335K | — | Filing → |